Esperto Medical
Esperto Medical is dedicated to delivering the future of healthcare through revolutionary non-invasive diagnostic technologies. Their patented Resonance Sonomanometry™ (RSM) technology uses sound waves to measure vital signs accurately and continuously without calibration or squeezing cuffs, aiming to improve vital sign monitoring for anyone, anywhere. The company is focused on expanding access to advanced cardiovascular monitoring, with applications in clinical, home, space, and pediatric settings.
Industries
Nr. of Employees
small (1-50)
Products
Prototype acoustic resonance-based continuous blood pressure monitor
A prototype system that measures arterial resonant frequencies and artery shape via multi-frequency acoustic sensing to provide continuous, calibration-free, noninvasive blood pressure estimates and longitudinal vital-sign data.
Prototype acoustic resonance-based continuous blood pressure monitor
A prototype system that measures arterial resonant frequencies and artery shape via multi-frequency acoustic sensing to provide continuous, calibration-free, noninvasive blood pressure estimates and longitudinal vital-sign data.
Services
Onsite studies recruiting healthy volunteers to evaluate a continuous noninvasive acoustic blood pressure method against cuff-based devices.
Onsite studies recruiting healthy volunteers to evaluate a continuous noninvasive acoustic blood pressure method against cuff-based devices.
Expertise Areas
- Continuous vital-sign monitoring
- Noninvasive hemodynamic sensing
- Clinical trial management and clinical operations
- Embedded real-time systems engineering
Key Technologies
- Acoustic resonance sensing
- Real-time embedded systems (millisecond precision)
- Digital signal processing (multi-frequency analysis)
- Machine learning for biosignals
News & Updates
Esperto Medical closed an oversubscribed Series A investment round to support productization and clinical testing of RSM technology for blood pressure monitoring.
Esperto was honored as Octane's Best Emerging Disruptor of 2024, recognizing its innovative contributions to medical technology.
Esperto was chosen as one of twelve startups for the Space Health Accelerator, focusing on medical technology for space exploration.
The company’s novel blood pressure measurement technique was published in PNAS Nexus, detailing its validation and potential.
Esperto joined the ARPA-H network to accelerate the commercialization of biomedical solutions.
Esperto was among ten finalists for a pediatric device competition, aiming to improve blood pressure monitoring in children.
Esperto Medical closed an oversubscribed Series A investment round to support productization and clinical testing of RSM technology for blood pressure monitoring.
Esperto was honored as Octane's Best Emerging Disruptor of 2024, recognizing its innovative contributions to medical technology.
Esperto was chosen as one of twelve startups for the Space Health Accelerator, focusing on medical technology for space exploration.
The company’s novel blood pressure measurement technique was published in PNAS Nexus, detailing its validation and potential.
Esperto joined the ARPA-H network to accelerate the commercialization of biomedical solutions.
Esperto was among ten finalists for a pediatric device competition, aiming to improve blood pressure monitoring in children.